Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone prolonged-release titration in cancer pain
ChiCTR-ORC-13003351Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxycodone in cancer pain, sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Successful titration within fewer than 2 to 3 titration cycles. Planned start Aug 2013; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR-ORC-13003351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ORC-13003351.